In the present study, we found that AF patients with high circulatory levels of relaxin-2 showed a decrease in the gene expression of two inflammatory markers (DEFA3 and IL-6) in leucocytes from LA plasma. This evidence concerns the gene RLN2 and atrial fibrillation.